PI
VYGR icon

Putnam Investments’s Voyager Therapeutics VYGR Stock Holding History

Putnam Investments’s Portfolio VYGR Stock Details VYGR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		$448K Sell
53,067
-22,500
-30% -$163K ﹤0.01% 958
2023
Q3 		$586K Buy
+75,567
New +$690K ﹤0.01% 901

Other funds holding VYGR

AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $12.9B AUM 52.69% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Putnam Investments's VYGR Position: Q4 2023 in Review

Putnam Investments reduced its Voyager Therapeutics (VYGR) stake by 30% in Q4 2023, selling an estimated $163K and leaving 53,067 shares worth $448K. The position accounts for ﹤0.01% of the portfolio, ranked #958.

Putnam Investments first reported a position in VYGR in Q3 2023 and has held it in 2 quarters since. The position peaked at $586K in Q3 2023. 107 funds tracked by Wall St. Rank hold VYGR as of Q4 2023.

  • Putnam Investments held 53,067 shares of Voyager Therapeutics worth $448K as of Q4 2023.
  • Putnam Investments sold 22,500 Voyager Therapeutics shares in Q4 2023, an estimated $163K.
  • Voyager Therapeutics made up ﹤0.01% of Putnam Investments's portfolio in Q4 2023, its #958 holding.
  • Putnam Investments first reported a position in Voyager Therapeutics in Q3 2023 and has held it in 2 quarters since.
  • Putnam Investments's Voyager Therapeutics position peaked at $586K in Q3 2023.
  • 107 funds tracked by Wall St. Rank held Voyager Therapeutics as of Q4 2023.

Based on Putnam Investments's 13F filing for Q4 2023, filed 14 Feb 2024.